Strata Skin Sciences Market Cap 2010-2023 | SSKN
Strata Skin Sciences market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Strata Skin Sciences market cap as of April 24, 2024 is $0.02B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.019B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.087B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.621B | 0.00 |
| Axonics (AXNX) | United States | $3.390B | 0.00 |
| 10x Genomics (TXG) | United States | $3.287B | 0.00 |
| Enovis (ENOV) | United States | $3.042B | 23.11 |
| Azenta (AZTA) | United States | $2.930B | 238.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.760B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.231B | 98.95 |
| Schrodinger (SDGR) | United States | $1.794B | 0.00 |
| Omnicell (OMCL) | United States | $1.306B | 31.94 |
| Phreesia (PHR) | United States | $1.305B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.856B | 0.00 |
| Standard BioTools (LAB) | United States | $0.743B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.330B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.162B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.157B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.154B | 0.00 |
| Augmedix (AUGX) | United States | $0.138B | 0.00 |
| Outset Medical (OM) | United States | $0.127B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| 111 (YI) | China | $0.091B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |